4.7 Article

Functional, morphological and molecular characterization of bladder dysfunction in streptozotocin-induced diabetic mice: evidence of a role for L-type voltage-operated Ca2+ channels

Journal

BRITISH JOURNAL OF PHARMACOLOGY
Volume 163, Issue 6, Pages 1276-1288

Publisher

WILEY
DOI: 10.1111/j.1476-5381.2011.01311.x

Keywords

diabetes; detrusor smooth muscle; bladder dysfunction; L-type Ca2+ channels; Rho-kinase

Funding

  1. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
  2. Biotechnology and Biological Sciences Research Council [BB/E527098/1] Funding Source: researchfish
  3. BBSRC [BB/E527098/1] Funding Source: UKRI

Ask authors/readers for more resources

BACKGROUND AND PURPOSE Diabetic cystopathy is one of the most common and incapacitating complications of diabetes mellitus. This study aimed to evaluate the functional, structural and molecular alterations of detrusor smooth muscle (DSM) in streptozotocin-induced diabetic mice, focusing on the contribution of Ca2+ influx through L-type voltage-operated Ca2+ channels (L-VOCC). EXPERIMENTAL APPROACH Male C57BL/6 mice were injected with streptozotocin (125 mg.kg(-1)). Four weeks later, contractile responses to carbachol, alpha,beta-methylene ATP, KCl, extracellular Ca2+ and electrical-field stimulation were measured in urothelium-intact DSM strips. Cystometry and histomorphometry were performed, and mRNA expression for muscarinic M-2/M-3 receptors, purine P2X1 receptors and L-VOCC in the bladder was determined. KEY RESULTS Diabetic mice exhibited higher bladder capacity, frequency, non-void contractions and post-void pressure. Increased bladder weight, wall thickness, bladder volume and neural tissue were observed in diabetic bladders. Carbachol, alpha,beta-methylene ATP, KCl, extracellular Ca2+ and electrical-field stimulation all produced greater DSM contractions in diabetic mice. The L-VOCC blocker nifedipine almost completely reversed the enhanced DSM contractions in bladders from diabetic animals. The Rho-kinase inhibitor Y27632 had no effect on the enhanced carbachol contractions in the diabetic group. Expression of mRNA for muscarinic M-3 receptors and L-VOCC were greater in the bladders of diabetic mice, whereas levels of M-2 and P2X1 receptors remained unchanged. CONCLUSIONS AND IMPLICATIONS Diabetic mice exhibit features of urinary bladder dysfunction, as characterized by overactive DSM and decreased voiding efficiency. Functional and molecular data suggest that overactive DSM in diabetes is the result of enhanced extracellular Ca2+ influx through L-VOCC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Andrology

Serum from Men with the Severe Form of COVID-19 Impairs the Nitric Oxide Signaling Pathway in Isolated Corpus Cavernosum from Mice: An In Vitro Study

Gabriela Reolon Passos, Guilherme Ruiz Leonardi, Mariana Goncalves de Oliveira, Erick de Toledo Gomes, Ana Carolina Ghezzi, Edson Antunes, Fernanda Andrade Orsi, Jose Luiz da Costa, Fabiola Zakia Monica

Summary: This study aimed to assess the effects of serum obtained from unvaccinated men with severe COVID-19 on isolated corpus cavernosum (CC) from mice. The results showed that the relaxation responses in CC incubated with COVID-19 serum were significantly reduced compared to the control serum. However, the relaxation induced by a specific activator was unaffected in CC stimulated with the COVID-19 serum. In addition, COVID-19 serum increased the expression of specific genes. These findings suggest that COVID-19 may lead to erectile dysfunction.

ANDROLOGIA (2023)

Article Pharmacology & Pharmacy

6-Nitrodopamine potentiates contractions of rat isolated vas deferens induced by noradrenaline, adrenaline, dopamine and electric field stimulation

Jose Britto-Junior, Antonio Tiago Lima, Rafael Campos, Alexandre Asturiano Giao, Gustavo Duarte Mendes, Luiza P. Ferreira-Novaes P. Silva, Adriano Fregonesi, Andre Sampaio Pupo, Edson Antunes, Gilberto De Nucci

Summary: 6-nitrodopamine (6-ND) is a novel endogenous catecholamine that modulates the contractility of rat isolated epididymal vas deferens (RIEVD). It interacts with classical catecholamines and potentiates their contractions in RIEVD. The activation of adrenergic terminals and pre-synaptic adrenoceptors may contribute to the potentiation of dopamine, noradrenaline, and adrenaline-induced contractions by 6-ND.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2023)

Article Biochemical Research Methods

Measurement of 6-cyanodopamine, 6-nitrodopa, 6-nitrodopamine and 6-nitroadrenaline by LC-MS/MS in Krebs-Henseleit solution. Assessment of basal release from rabbit isolated right atrium and ventricles

Gilberto Quirino Junior, Jose Britto-Junior, Tainah Babadopulos Magalhaes, Rafael Campos, Kudzai L. Nyamkondiwa, Kameron L. Klugh, Larryn W. Peterson, Angela Corvino, Rosa Sparaco, Francesco Frecentese, Giuseppe Caliendo, Gilberto De Nucci

Summary: This study presents the validation of a sensitive LC-MS/MS method for determining nitrocatecholamines in Krebs-Henseleit solution. The method was used to investigate the basal release of catecholamines from rabbit isolated atria and ventricles.

BIOMEDICAL CHROMATOGRAPHY (2023)

Article Medicine, Research & Experimental

Release of 6-nitrodopamine from human popliteal artery and vein

Luis Frederico Gerbase de Oliveira, Jose Britto Junior, Antonio Tiago Lima, Manoel Odorico Moraes, Maria Elisabete A. Moraes, Valeria Barbosa de Souza, Andre Almeida Schenka, Fabiola Zakia Monica, Gilberto De Nucci

Summary: The study found that 6-Nitrodopamine (6-ND) can be released from human umbilical cord vessels and cause vascular relaxation by acting as a dopamine D2-receptor antagonist. It was also found that human peripheral vessels obtained from patients who have undergone surgery for leg amputation release 6-ND and it has action in these tissues. The results indicate that 6-nitrodopamine is released from human peripheral artery and vein rings, and selective dopamine D2-receptor antagonists such as 6-ND may have therapeutic potential in the treatment of human peripheral vascular diseases.

LIFE SCIENCES (2023)

Article Biology

6-Nitrodopamine Is the Most Potent Endogenous Positive Inotropic Agent in the Isolated Rat Heart

Jose Britto-Junior, Lincoln Rangel Medeiros-Teixeira, Antonio Tiago Lima, Leticia Costa Dassow, Rodrigo alvaro Brandao Lopes-Martins, Rafael Campos, Manoel Odorico Moraes, Maria Elisabete A. Moraes, Edson Antunes, Gilberto De Nucci

Summary: The study found that 6-nitrodopamine is the major catecholamine released from rat isolated ventricles and is 1000 times more potent than dopamine and noradrenaline in increasing heart inotropism. It is selectively blocked by atenolol.

LIFE-BASEL (2023)

Article Biology

Relaxation of thoracic aorta and pulmonary artery rings of marmosets (Callithrix spp.) by endothelium-derived 6-nitrodopamine

J. Britto-Junior, A. T. Lima, J. S. Santos-Xavier, P. Gonzalez, F. Z. Monica, R. Campos, V. B. de Souza, A. A. Schenka, E. Antunes, G. De Nucci

Summary: This study investigated the release of 6-nitrodopamine in the thoracic aorta and pulmonary artery rings of marmosets. The results showed that 6-nitrodopamine is the major catecholamine released by marmoset vascular tissues. It acts as a potent and selective antagonist of dopamine D2-like receptors and induces vasodilation by releasing NO.

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2023)

Article Physiology

Evidence that methylglyoxal and receptor for advanced glycation end products are implicated in bladder dysfunction of obese diabetic ob/ob mice

Akila L. Oliveira, Matheus L. Medeiros, Ana Carolina Ghezzi, Gabriel Alonso dos Santos, Glaucia Coelho Mello, Fabiola Z. Monica, Edson Antunes

Summary: High levels of MGO and AGEs, along with activation of the RAGE pathway, contribute to diabetes-associated bladder dysfunction. Treatment with the AGE breaker ALT-711 can reduce MGO levels and improve bladder function in diabetic mice.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2023)

Meeting Abstract Pharmacology & Pharmacy

Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study

Carlos Sverdloff, Clive Page, Gilberto De Nucci, Dave Singh

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Meeting Abstract Pharmacology & Pharmacy

Selective role of eNOS on the chronotropic effect of endogenous 6-nitrodopamine (6-ND) in mice isolated atria

Ms Vivian Fuguhara, Jose Britto-Junior, Rafael Campos, Silvana Chiavegatto, Fernando Cunha, Edson Antunes, Gilberto De Nucci

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Meeting Abstract Pharmacology & Pharmacy

Basal release and action of 6-nitrodopamine from human popliteal artery and vein in vitro

Luis Frederico Gerbase De Oliveira, Antonio Tiago Lima, Jose Britto-Junior, Rafael Campos, Gilberto De Nucci

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Meeting Abstract Pharmacology & Pharmacy

Potentiation by 6-nitrodopamine of the chronotropic effect of dopamine, noradrenaline, and adrenaline in the rat isolated atria

Antonio Lima, Jose Britto-Junior, Vivian Fuguhara, Edson Antunes, Gilberto De Nucci

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Meeting Abstract Pharmacology & Pharmacy

Evaluation of permeability and local tolerability of dapaconazole administered by intravaginal route in rabbits

Gustavo Mendes, Renato Mello, Andre Freitas, Rafael Campos, Gilberto De Nucci

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Meeting Abstract Pharmacology & Pharmacy

6-nitrodopamine is the most potent endogenous positive inotropic agent in the rat isolated heart

Jose Britto-Junior, Antonio Tiago Lima, Rafael Campos, Edson Antunes, Gilberto De Nucci

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Meeting Abstract Pharmacology & Pharmacy

Basal release of 6-cyanodopamine, 6-nitrodopa, 6-nitrodopamine and 6-nitroadrenaline from rabbit isolated ventricles

Rafael Campos, Jose-Britto Junior, Britto Junior, Gilberto Quirino-Santos, Kudzai L. Nyamkondiwa, Kameron L. Klugh, Dra Larryn W. Peterson, Gilberto De Nucci

BRITISH JOURNAL OF PHARMACOLOGY (2023)

No Data Available